Therapeutic challenges of extrapulmonary dual organ system involvement in COVID‑19: A case report
- Karniza Khalid
- Suhaila Ab Wahab
- Khaulah Karimah Azni
Affiliations: Clinical Research Centre, Hospital Tuanku Fauziah, Ministry of Health Malaysia, 01000 Kangar, Perlis, Malaysia, Department of Internal Medicine (Infectious Disease), Hospital Tuanku Fauziah, Ministry of Health Malaysia, 01000 Kangar, Perlis, Malaysia, Department of Radiology, Hospital Tuanku Fauziah, Ministry of Health Malaysia, 01000 Kangar, Perlis, Malaysia
- Published online on: December 7, 2021 https://doi.org/10.3892/mi.2021.24
Copyright: © Khalid
et al. This is an open access article distributed under the
terms of Creative
Commons Attribution License.
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Respiratory symptoms and signs remain the hallmark of coronavirus disease 2019 (COVID‑19) infection. However, extrapulmonary manifestations of COVID‑19 are not uncommon, and are likely to be underreported. The present study describes a clinical case of a 64‑year‑old patient with COVID‑19 with marked extrapulmonary manifestations in the setting of strong positive reactions with cycle threshold values of reverse transcription polymerase chain reaction for COVID‑19. He presented with asymptomatic bradycardia with wide pulse pressure, eventually requiring transvenous cardiac pacing. He later complained of lower abdominal pain associated with no bowel movements for four days. The computed tomography examination of the abdomen revealed circumferential wall thickening at the proximal ascending colon, suggestive of inflammatory changes and features of obstruction in the presence of inguinal hernia. Despite aggressive resuscitative efforts, the patient continued to deteriorate with multiorgan failure, and eventually succumbed to the disease after 6 days of hospitalization. The present case study deliberates the sharing of our clinical experience and therapeutic challenges in the management of COVID‑19 with complex extrapulmonary manifestation.